Rocket Pharmaceuticals, Inc.(RCKT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

RCKT Rocket Pharmaceuticals, Inc.

休市中 09-06 16:00:00 EDT

18.51

-0.02

-0.11%

盘后18.51

+0.000.00%

18:01 EDT

最高19.24	最低17.91	成交量61.93万
今开18.70	昨收18.53	日振幅7.18%
总市值16.85亿	流通市值13.13亿	总股本9,101万
成交额1,148万	换手率0.87%	流通股本7,093万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"RCKT","market":"US","secType":"STK","nameCN":"Rocket Pharmaceuticals, Inc.","latestPrice":18.51,"timestamp":1725652800000,"preClose":18.53,"halted":0,"volume":619321,"hourTrading":{"tag":"盘后","latestPrice":18.51,"preClose":18.51,"latestTime":"18:01 EDT","volume":21559,"amount":399056.29,"timestamp":1725660066980},"delay":0,"floatShares":70928143,"shares":91014473,"eps":-2.785941,"marketStatus":"休市中","marketStatusCode":7,"change":-0.02,"latestTime":"09-06 16:00:00 EDT","open":18.7,"high":19.24,"low":17.91,"amount":11480859.362257,"amplitude":0.071775,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.785941,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1725868800000},"adr":0,"listingDate":1424235600000,"adjPreClose":18.53,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":18.53,"preClose":18.53,"latestTime":"08:05 EDT","volume":8,"amount":148.24,"timestamp":1725624306222},"postHourTrading":{"tag":"盘后","latestPrice":18.51,"preClose":18.51,"latestTime":"18:01 EDT","volume":21559,"amount":399056.29,"timestamp":1725660066980},"volumeRatio":1.1096536415538492,"impliedVol":0.5899,"impliedVolPercentile":0.2659},"requestUrl":"/m/hq/s/RCKT/wiki","defaultTab":"wiki","newsList":[{"id":"2459720814","title":"Rocket Pharmaceuticals, Inc.2024财年第二财季实现净利润-69.65百万美元，同比减少6.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459720814","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459720814?lang=zh_cn&edition=full","pubTime":"2024-08-16 00:02","pubTimestamp":1723737730,"startTime":"0","endTime":"0","summary":"8月16日，Rocket Pharmaceuticals, Inc.公布财报，公告显示公司2024财年第二财季净利润为-69.65百万美元，同比减少6.01%；其中营业收入为0.00美元，每股基本收益为-0.74美元。从资产负债表来看，Rocket Pharmaceuticals, Inc.总负债61.78百万美元，其中短期债务2.86百万美元，资产负债比为0.08，流动比率为0.08。机构评级：截至2024年8月16日，当前有13家机构对Rocket Pharmaceuticals, Inc.目标价做出预测，其中目标均价为47.15美元，其中最低目标价为31.00美元，最高目标价为65.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408160002289f2e4417&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408160002289f2e4417&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RCKT"],"gpt_icon":0},{"id":"2459446626","title":"Rocket Pharmaceuticals, Inc.盘中异动 大幅下挫5.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459446626","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459446626?lang=zh_cn&edition=full","pubTime":"2024-08-14 22:43","pubTimestamp":1723646609,"startTime":"0","endTime":"0","summary":"北京时间2024年08月14日22时43分，Rocket Pharmaceuticals, Inc.股票出现波动，股价急速跳水5.85%。Rocket Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.31%。其相关个股中，Zura Bio Limited C/Wts 、Newamsterdam Pharma Co Nv C/Wts 、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Genprex, Inc.、Conduit Pharmaceuticals Inc.、Tc Biopharm  Plc较为活跃，换手率分别为84.87%、71.13%、61.18%，振幅较大的相关个股有Seastar Medical Holding Corp C/Wts 28/10/2027 、Genprex, Inc.、Tc Biopharm  Plc，振幅分别为60.83%、58.52%、49.86%。Rocket Pharmaceuticals, Inc.公司简介：Rocket Pharmaceuticals Inc 是一家后期生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240814224329a1d44939&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240814224329a1d44939&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RCKT"],"gpt_icon":0},{"id":"2457734618","title":"Rocket Pharmaceuticals, Inc.盘中异动 下午盘股价大跌5.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457734618","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457734618?lang=zh_cn&edition=full","pubTime":"2024-08-08 02:15","pubTimestamp":1723054533,"startTime":"0","endTime":"0","summary":"北京时间2024年08月08日02时15分，Rocket Pharmaceuticals, Inc.股票出现异动，股价急速跳水5.44%。Rocket Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为2.46%。其相关个股中，G1 Therapeutics, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 、Salarius Pharmaceuticals, Inc.涨幅较大，Aditxt, Inc.、Salarius Pharmaceuticals, Inc.、Scorpius Holdings, Inc.较为活跃，换手率分别为5137.29%、2321.51%、326.10%，振幅较大的相关个股有Aditxt, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 、Salarius Pharmaceuticals, Inc.，振幅分别为101.30%、69.66%、60.22%。Rocket Pharmaceuticals, Inc.公司简介：Rocket Pharmaceuticals Inc 是一家后期生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808021534af966d52&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808021534af966d52&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RCKT","BK4139"],"gpt_icon":0},{"id":"2457221090","title":"坎托菲茨杰拉德公司：重申Rocket Pharmaceuticals(RCKT.US)评级，由增持调整至增持评级, 目标价由65.","url":"https://stock-news.laohu8.com/highlight/detail?id=2457221090","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457221090?lang=zh_cn&edition=full","pubTime":"2024-08-06 23:20","pubTimestamp":1722957623,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["RCKT","BK4139"],"gpt_icon":0},{"id":"2457022893","title":"Rocket Pharmaceuticals Inc    预计每股亏损 74 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2457022893","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457022893?lang=zh_cn&edition=full","pubTime":"2024-08-06 23:11","pubTimestamp":1722957072,"startTime":"0","endTime":"0","summary":"   * Rocket Pharmaceuticals Inc    预计将在11月4日公布截至2024年9月30日的业绩报告(估计)，季度收入将有所增长。* LSEG 分析师对 Rocket Pharmaceuticals Inc 的平均预期是每股亏损 74 美分。* 华尔街对 Rocket Pharmaceuticals Inc 的 12 个月目标价中值为 47.00 美元，高于其上次收盘价 19.96 美元。8月6日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Rocket Pharmaceuticals Inc    预计每股亏损 74 美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RCKT"],"gpt_icon":0},{"id":"2456956430","title":"Rocket Pharmaceuticals, Inc.盘中异动 大幅下挫5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2456956430","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456956430?lang=zh_cn&edition=full","pubTime":"2024-08-01 23:37","pubTimestamp":1722526643,"startTime":"0","endTime":"0","summary":"北京时间2024年08月01日23时37分，Rocket Pharmaceuticals, Inc.股票出现异动，股价急速下挫5.00%。Rocket Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.92%。其相关个股中，Dermata Therapeutics, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 涨幅较大，Dermata Therapeutics, Inc.、Windtree Therapeutics, Inc.、Immuneering Corporation较为活跃，换手率分别为450.94%、331.77%、205.16%，振幅较大的相关个股有Immuneering Corporation、Dermata Therapeutics, Inc.、Windtree Therapeutics, Inc.，振幅分别为42.48%、41.85%、40.35%。Rocket Pharmaceuticals, Inc.公司简介：Rocket Pharmaceuticals Inc 是一家后期生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240801233723aefcb93d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240801233723aefcb93d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RCKT"],"gpt_icon":0},{"id":"2454723438","title":"Rocket Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2454723438","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454723438?lang=zh_cn&edition=full","pubTime":"2024-07-25 22:17","pubTimestamp":1721917044,"startTime":"0","endTime":"0","summary":"北京时间2024年07月25日22时17分，Rocket Pharmaceuticals, Inc.股票出现异动，股价急速上涨5.11%。Rocket Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.96%。其相关个股中，Psyence Biomedical Ltd.、Psyence Biomedical Ltd C/Wts 25/01/2029、Salarius Pharmaceuticals, Inc.涨幅较大，Salarius Pharmaceuticals, Inc.、Psyence Biomedical Ltd.、60 Degrees Pharmaceuticals, Inc.较为活跃，换手率分别为2074.17%、414.19%、162.20%，振幅较大的相关个股有Psyence Biomedical Ltd.、Salarius Pharmaceuticals, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为114.90%、98.60%、50.00%。Rocket Pharmaceuticals, Inc.公司简介：Rocket Pharmaceuticals Inc 是一家后期生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024072522172496820546&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024072522172496820546&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RCKT","BK4139"],"gpt_icon":0},{"id":"2453714047","title":"Rocket Pharmaceuticals, Inc.盘中异动 股价大涨5.00%报23.96美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2453714047","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453714047?lang=zh_cn&edition=full","pubTime":"2024-07-23 03:22","pubTimestamp":1721676141,"startTime":"0","endTime":"0","summary":"北京时间2024年07月23日03时22分，Rocket Pharmaceuticals, Inc.股票出现异动，股价急速上涨5.00%。Rocket Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.94%。其相关个股中，Tc Biopharm  Plc C/Wts 10/02/2028 、Pasithea Therapeutics Corp C/Wts 12/08/2026 、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 涨幅较大，Hepion Pharmaceuticals, Inc.、Scisparc Ltd.、Salarius Pharmaceuticals, Inc.较为活跃，换手率分别为123.78%、116.51%、85.54%，振幅较大的相关个股有Anew Medical Inc C/Wts 21/06/2029 、Mei Pharma, Inc.、木薯科学，振幅分别为44.07%、37.06%、33.41%。Rocket Pharmaceuticals, Inc.公司简介：Rocket Pharmaceuticals Inc 是一家后期生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407230322219681ef26&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407230322219681ef26&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RCKT","BK4139"],"gpt_icon":0},{"id":"2448228481","title":"加拿大投资银行集团：维持Rocket Pharmaceuticals(RCKT.US)评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2448228481","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448228481?lang=zh_cn&edition=full","pubTime":"2024-07-03 22:48","pubTimestamp":1720018104,"startTime":"0","endTime":"0","summary":"加拿大投资银行集团：维持rocket Pharmaceuticals(RCKT.US)评级，由买入调整至买入评级,目标价由49.00美元调整至40.00美元。Rocket Pharmaceuticals(RCKT.US)公司简介：Rocket Pharmaceuticals Inc是一家临床阶段的生物制药公司。它专注于开发针对罕见和破坏性儿科疾病的基因疗法。该公司的管道产品包括用于达能病的RP-A501、用于范科尼贫血的RP-L102、用于白细胞粘附的RP-L201、用于苯丙酸激酶缺乏症的RP-L301和用于婴儿恶性骨质疏松症的RP-L401。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407032255439efc7d3d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407032255439efc7d3d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RCKT"],"gpt_icon":0},{"id":"2448291028","title":"Rocket Pharmaceuticals, Inc.盘中异动 大幅下跌5.06%报20.44美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448291028","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448291028?lang=zh_cn&edition=full","pubTime":"2024-07-02 00:14","pubTimestamp":1719850496,"startTime":"0","endTime":"0","summary":"北京时间2024年07月02日00时14分，Rocket Pharmaceuticals, Inc.股票出现波动，股价快速跳水5.06%。Rocket Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.33%。其相关个股中，Senti Biosciences, Inc.、Engene Holdings Inc C/Wts 31/10/2028  Cl A、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 涨幅较大，Senti Biosciences, Inc.、Geovax Labs, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为679.70%、179.35%、112.66%，振幅较大的相关个股有Senti Biosciences, Inc.、Cingulate Inc.、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 ，振幅分别为101.49%、67.19%、56.57%。Rocket Pharmaceuticals, Inc.公司简介：Rocket Pharmaceuticals Inc 是一家后期生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240702001457941f2ca5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240702001457941f2ca5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RCKT"],"gpt_icon":0},{"id":"2448952768","title":"美国研究综述-AT&T, ATI, 加利福尼亚资源公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2448952768","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448952768?lang=zh_cn&edition=full","pubTime":"2024-07-01 15:23","pubTimestamp":1719818605,"startTime":"0","endTime":"0","summary":"    路透7月1日 - 华尔街证券分析师周一调整了对几家美国上市公司的评级和目标价，其中包括 AT&T、ATI 和加州资源公司。要闻  * AT&T Inc   ：摩根大通将其股票列入美国分析师关注名单  * ATI Inc   ：摩根大通将其股票从美国分析师关注名单中删除  * 加州资源公司   ：Gerdes Energy Research将其评级从 \"买入 \"下调至 \"中性\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4588","BK4505","T","CHRS","HXL","ACCD","LU1621768115.EUR","BK4196","APLS","LU0321505439.SGD","BK4207","SM","IE00B19Z3581.USD","WBA","IE00B7SZLL34.SGD","BK4589","CENT","BK4187","IE00BSNM7G36.USD","FCNCA","EQT","OVV","LU2065732104.USD","RIVN","KNTK","NOG","ELAN","LU0053671581.USD","BK4211","ATI","BK4507","BK4562","PTCT","BK4561","LU1621767737.EUR","INSM","BK4144","ILMN","RCKT","BK4213","LU0889565916.HKD","SPB","TSHA","CRC","NKLA","LU1621767810.EUR","BK4018","LU0109394709.USD","BK4585"],"gpt_icon":0},{"id":"2447634932","title":"Chardan Capital：维持Rocket Pharmaceuticals(RCKT.US)评级，由买入调整至买入评级, 目标价由62.","url":"https://stock-news.laohu8.com/highlight/detail?id=2447634932","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2447634932?lang=zh_cn&edition=full","pubTime":"2024-06-29 03:05","pubTimestamp":1719601537,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["RCKT","BK4139"],"gpt_icon":0},{"id":"2446683822","title":"Rocket Pharmaceuticals, Inc.盘中异动 股价大跌12.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446683822","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446683822?lang=zh_cn&edition=full","pubTime":"2024-06-28 21:31","pubTimestamp":1719581496,"startTime":"0","endTime":"0","summary":"北京时间2024年06月28日21时31分，Rocket Pharmaceuticals, Inc.股票出现波动，股价大幅下挫12.27%。截至发稿，该股报18.80美元/股，成交量16.342万股，换手率0.18%，振幅2.08%。Rocket Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.03%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Revolution Medicines Inc C/Wts 17/12/2026 、180 Life Sciences Corp C/Wts 07/11/2025涨幅较大，Clearmind Medicine Inc.、Carisma Therapeutics, Inc.、Geovax Labs, Inc.较为活跃，换手率分别为189.48%、17.40%、15.42%，振幅较大的相关个股有Clearmind Medicine Inc.、Carisma Therapeutics, Inc.、Nanobiotix，振幅分别为10.45%、10.16%、8.84%。Rocket Pharmaceuticals, Inc.公司简介：Rocket Pharmaceuticals Inc 是一家后期生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406282131369f7138c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406282131369f7138c9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RCKT","BK4139"],"gpt_icon":0},{"id":"2446501586","title":"BUZZ-Rocket Pharma 因 FDA 拒绝批准其免疫紊乱基因疗法而暴跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2446501586","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446501586?lang=zh_cn&edition=full","pubTime":"2024-06-28 20:16","pubTimestamp":1719577013,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    6月28日 - ** 基因疗法开发商Rocket Pharmaceuticals   股价盘前下跌约14.8%，至18.26美元** 该公司称，美国食品和药物管理局已拒绝批准 (link) 其基因疗法 kresladi 用于治疗一种罕见的严重儿科疾病，这种疾病会导致免疫系统功能紊乱。** 称FDA要求提供与基因疗法某些过程有关的有限补充信息，以便完成审查** Kresladi正在接受审查，用于治疗严重白细胞粘附缺陷-I(LAD-I)，这种疾病可能导致反复感染。** 截至上次收盘，股价累计下跌 28.5","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RCKT","BUZZ","BK4139"],"gpt_icon":0},{"id":"2446037535","title":"美国 FDA 拒绝批准 Rocket Pharma 的免疫紊乱基因疗法","url":"https://stock-news.laohu8.com/highlight/detail?id=2446037535","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446037535?lang=zh_cn&edition=full","pubTime":"2024-06-28 19:30","pubTimestamp":1719574217,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    路透6月28日 - 美国食品和药物管理局拒绝批准Rocket Pharmaceuticals公司  的基因疗法治疗一种罕见的严重儿科疾病，这种疾病会导致免疫系统失常。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RCKT"],"gpt_icon":0},{"id":"2446944313","title":"Rocket Pharmaceuticals, Inc.盘中异动 早盘快速跳水5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446944313","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446944313?lang=zh_cn&edition=full","pubTime":"2024-06-26 22:28","pubTimestamp":1719412103,"startTime":"0","endTime":"0","summary":"北京时间2024年06月26日22时28分，Rocket Pharmaceuticals, Inc.股票出现波动，股价急速跳水5.03%。Rocket Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.87%。其相关个股中，Anew Medical, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、180 Life Sciences Corp C/Wts 07/11/2025涨幅较大，Anew Medical, Inc.、Cns Pharmaceuticals, Inc.、Gri Bio, Inc.较为活跃，换手率分别为469.01%、111.13%、91.29%，振幅较大的相关个股有Anew Medical, Inc.、Effector Therapeutics Inc C/Wts 31/12/2025 、Moolec Science Sa C/Wts ，振幅分别为107.88%、51.85%、39.62%。Rocket Pharmaceuticals, Inc.公司简介：Rocket Pharmaceuticals Inc 是一家后期生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240626222823941f16b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240626222823941f16b8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RCKT","BK4139"],"gpt_icon":0},{"id":"2445008455","title":"Rocket Pharmaceuticals, Inc.盘中异动 快速上涨5.07%报23.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2445008455","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2445008455?lang=zh_cn&edition=full","pubTime":"2024-06-24 22:34","pubTimestamp":1719239691,"startTime":"0","endTime":"0","summary":"北京时间2024年06月24日22时34分，Rocket Pharmaceuticals, Inc.股票出现波动，股价急速拉升5.07%。Rocket Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.68%。其相关个股中，Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Geovax Labs Inc C/Wts 29/09/2025、阿里拉姆制药涨幅较大，Revelation Biosciences, Inc.、Geovax Labs, Inc.、Gri Bio, Inc.较为活跃，换手率分别为1653.84%、126.27%、74.73%，振幅较大的相关个股有Effector Therapeutics Inc C/Wts 31/12/2025 、Revelation Biosciences Inc C/Wts 10/01/2027 、Hcw Biologics Inc.，振幅分别为139.27%、59.54%、53.94%。Rocket Pharmaceuticals, Inc.公司简介：Rocket Pharmaceuticals Inc 是一家后期生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240624223451941f096e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240624223451941f096e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RCKT","BK4139"],"gpt_icon":0},{"id":"2445763873","title":"Rocket Pharmaceuticals, Inc.盘中异动 早盘快速拉升5.52%报22.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2445763873","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2445763873?lang=zh_cn&edition=full","pubTime":"2024-06-21 21:41","pubTimestamp":1718977294,"startTime":"0","endTime":"0","summary":"北京时间2024年06月21日21时41分，Rocket Pharmaceuticals, Inc.股票出现异动，股价快速拉升5.52%。Rocket Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.39%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Ocean Biomedical Inc C/Wts 14/02/2028 、Sarepta Therapeutics, Inc.涨幅较大，Qualigen Therapeutics, Inc.、Kintara Therapeutics, Inc.、Mustang Bio, Inc.较为活跃，换手率分别为196.63%、34.78%、25.95%，振幅较大的相关个股有Geovax Labs Inc C/Wts 29/09/2025、Mustang Bio, Inc.、Humacyte Inc C/Wts 27/08/2026 ，振幅分别为52.38%、34.88%、26.13%。Rocket Pharmaceuticals, Inc.公司简介：Rocket Pharmaceuticals Inc 是一家后期生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240621214134af8ea6a3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240621214134af8ea6a3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RCKT"],"gpt_icon":0},{"id":"2442557837","title":"Rocket Pharmaceuticals, Inc.盘中异动 早盘急速拉升5.46%报24.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2442557837","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2442557837?lang=zh_cn&edition=full","pubTime":"2024-06-12 21:31","pubTimestamp":1718199111,"startTime":"0","endTime":"0","summary":"北京时间2024年06月12日21时31分，Rocket Pharmaceuticals, Inc.股票出现异动，股价大幅上涨5.46%。截至发稿，该股报24.16美元/股，成交量1.1356万股，换手率0.01%，振幅1.75%。Rocket Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.34%。其相关个股中，Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Avidity Biosciences, Inc.、Molecular Partners Ag涨幅较大，Tonix Pharmaceuticals Holding Corp.、Tracon Pharmaceuticals, Inc.、Jaguar Health, Inc.较为活跃，换手率分别为36.85%、19.08%、3.60%，振幅较大的相关个股有Passage Bio, Inc.、Xortx Therapeutics Inc.、Akari Therapeutics Plc，振幅分别为21.10%、20.93%、8.28%。Rocket Pharmaceuticals, Inc.公司简介：Rocket Pharmaceuticals Inc 是一家后期生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612213151941ee0b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612213151941ee0b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RCKT"],"gpt_icon":0},{"id":"2432897050","title":"Rocket Pharmaceuticals, Inc.盘中异动 大幅上涨5.36%报23.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432897050","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2432897050?lang=zh_cn&edition=full","pubTime":"2024-05-03 21:33","pubTimestamp":1714743212,"startTime":"0","endTime":"0","summary":"北京时间2024年05月03日21时33分，Rocket Pharmaceuticals, Inc.股票出现异动，股价急速上涨5.36%。截至发稿，该股报23.99美元/股，成交量9443股，换手率0.01%，振幅0.53%。Rocket Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.15%。其相关个股中，Vaxxinity, Inc.、Ardelyx, Inc.、Jaguar Health, Inc.涨幅较大，Allarity Therapeutics, Inc.、Vaxxinity, Inc.、Jaguar Health, Inc.较为活跃，换手率分别为69.18%、22.21%、11.11%，振幅较大的相关个股有Rani Therapeutics Holdings, Inc.、Organovo Holdings, Inc.、Relay Therapeutics, Inc.，振幅分别为15.86%、15.78%、13.56%。Rocket Pharmaceuticals, Inc.公司简介：Rocket Pharmaceuticals Inc 是一家后期生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240503213333861ead44&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240503213333861ead44&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RCKT","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.rocketpharma.com","stockEarnings":[{"period":"1week","weight":-0.018},{"period":"1month","weight":-0.0206},{"period":"3month","weight":-0.1839},{"period":"6month","weight":-0.3358},{"period":"1year","weight":0.1656},{"period":"ytd","weight":-0.3824}],"compareEarnings":[{"period":"1week","weight":-0.0414},{"period":"1month","weight":0.0418},{"period":"3month","weight":0.0119},{"period":"6month","weight":0.056},{"period":"1year","weight":0.2147},{"period":"ytd","weight":0.1369}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Rocket Pharmaceuticals, Inc.于1999年7月7日根据特拉华州法律注册成立。该公司是一家完全整合的、处于后期阶段的生物技术公司，专注于开发首创、唯一和同类最佳的基因疗法，具有直接的靶向作用机制和明确的临床终点，用于罕见和破坏性疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.057456},{"month":2,"riseRate":0.444444,"avgChangeRate":-0.010173},{"month":3,"riseRate":0.4,"avgChangeRate":-0.043717},{"month":4,"riseRate":0.6,"avgChangeRate":0.000719},{"month":5,"riseRate":0.4,"avgChangeRate":0.027106},{"month":6,"riseRate":0.6,"avgChangeRate":-0.003251},{"month":7,"riseRate":0.6,"avgChangeRate":0.128159},{"month":8,"riseRate":0.4,"avgChangeRate":-0.038018},{"month":9,"riseRate":0.6,"avgChangeRate":0.104335},{"month":10,"riseRate":0.555556,"avgChangeRate":0.052535},{"month":11,"riseRate":0.666667,"avgChangeRate":0.043321},{"month":12,"riseRate":0.555556,"avgChangeRate":0.136427}],"exchange":"NASDAQ","name":"Rocket Pharmaceuticals, Inc.","nameEN":"Rocket Pharmaceuticals, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.3","shortVersion":"4.26.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Rocket Pharmaceuticals, Inc.(RCKT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Rocket Pharmaceuticals, Inc.(RCKT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Rocket Pharmaceuticals, Inc.,RCKT,Rocket Pharmaceuticals, Inc.股票,Rocket Pharmaceuticals, Inc.股票老虎,Rocket Pharmaceuticals, Inc.股票老虎国际,Rocket Pharmaceuticals, Inc.行情,Rocket Pharmaceuticals, Inc.股票行情,Rocket Pharmaceuticals, Inc.股价,Rocket Pharmaceuticals, Inc.股市,Rocket Pharmaceuticals, Inc.股票价格,Rocket Pharmaceuticals, Inc.股票交易,Rocket Pharmaceuticals, Inc.股票购买,Rocket Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Rocket Pharmaceuticals, Inc.(RCKT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Rocket Pharmaceuticals, Inc.(RCKT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}